AIOLOS Variants Causing Immunodeficiency in Human and Mice

AIOLOS is encoded by IKZF3 and is a member of the IKAROS zinc finger transcription factor family. Heterozygous missense variants in the second zinc finger of AIOLOS have recently been reported to be found in the families of patients with inborn errors of immunity. The AIOLOS G159R variant was identi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 866582
Main Authors Yamashita, Motoi, Morio, Tomohiro
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AIOLOS is encoded by IKZF3 and is a member of the IKAROS zinc finger transcription factor family. Heterozygous missense variants in the second zinc finger of AIOLOS have recently been reported to be found in the families of patients with inborn errors of immunity. The AIOLOS G159R variant was identified in patients with B-lymphopenia and familial Epstein–Barr virus-associated lymphoma. Early B-cell progenitors were significantly reduced in the bone marrow of patients with AIOLOS G159R . Another variant, AIOLOS N160S was identified in the patients presented with hypogammaglobulinemia, susceptibility to Pneumocystis jirovecii pneumonia, and chronic lymphocytic leukemia. Patients with AIOLOS N160S had mostly normal B cell counts but showed increased levels of CD21 lo B cells, decreased CD23 expression, and abrogated CD40 response. Both variants were determined to be loss-of-function. Mouse models harboring the corresponding patient’s variants recapitulated the phenotypes of the patients. AIOLOS is therefore a novel disease-causing gene in human adaptive immune deficiency.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Luigi Daniele Notarangelo, National Institute of Allergy and Infectious Diseases (NIH), United States; Hyun Park, National Cancer Institute (NIH), United States
This article was submitted to Primary Immunodeficiencies, a section of the journal Frontiers in Immunology
Edited by: Hye Sun Kuehn, National Institutes of Health (NIH), United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.866582